2 not yet recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 2 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Thinness: new trials by email Literature Review of Thinness trials Research Report on Thinness
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss ponsegromab, placebo - Non-small Cell Lung Cancer (NSCLC), Cachexia | Phase 1 | Not yet recruiting | Pfizer | 80 | 2026-10-23 | 2026-09-25 |
| Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia DS010 injection - Cancer, Cachexia | Phase 1 / Phase 2 | Not yet recruiting | Dartsbio Pharmaceuticals Ltd. | 58 | 2026-04-30 | 2026-04-15 |
Cachexia (2) · Neoplasms (2) · Anorexia (1) · Carcinoma, Non-Small-Cell Lung (1) · Fatigue (1) · Weight Loss (1)
Body Weight (2) · Body Weight Changes (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms by Site (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Signs and Symptoms, Digestive (1) · Thoracic Neoplasms (1) · Weight Loss (1)
Dartsbio Pharmaceuticals Ltd. (1) · Pfizer (1)
China (2) · United States (1)